Download PDF

Other users also viewed these articles

Prevalence by health areas of chronic kidney disease in the diabetic population of Extremadura in 2012, 2013 and 2014. An observational study Leandro Fernández-Fernández; Javier Goujat-Salas; Carmen Ceballos-Malagón; Manuel Tejero-Mas; Francisco Luis Pérez-Caballero; Francisco Buitrago-Ramírez;
Nefrologia (English Version). 2022;42:704-13
Safety and efficacy of sodium-glucose co-transporter-2 inhibitors and aldosterone inhibitors combinations in chronic kidney disease: A systematic review and meta-analysis Ahmed W. Hageen; Reem Sayad; Alyaa Khaled Abdelmonem; Katia Latifa; Lina Musallam; Moustafa Abouelkheir; Sherif Mira; Ahmed Awad; Ahmed Afsa; Waleed Nassar; Gehad El Ashal; Mohamed Elmasry; Eshak I. Bahbah;
Nefrologia (English Version). 2025;45:
Cardiovascular and renal outcomes according to KDIGO stages of chronic kidney disease in the Spanish population: Insights from real-world evidence Rafael Santamaria; Carlos Escobar; Unai Aranda; Beatriz Palacios; Margarita Capel; Ignacio Hernández; Ana Cebrián; Roberto Alcázar; Manuel Gorostidi;
Nefrologia (English Version). 2025;45: